Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy S Frieling

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cancer Immunology, Immunotherapy : CII|March 2, 2020
Neutrophils are mediators of metastatic prostate cancer progression in boneDiane L Costanzo-Garvey, Tyler Keeley, Adam J Case, et al.
Molecular Cancer Research : MCR|April 29, 2025
Targeted Deletion of Cxcl1 in MSCs Promotes Osteogenesis and Suppresses Bone Metastatic Prostate CancerCatherine S Johnson, Diane Costanzo-Garvey, Julio C Valencia, et al.
Nature Communications|March 20, 2024
The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant diseaseRyan T Bishop, Anna K Miller, Matthew Froid, et al.
Science Advances|May 3, 2023
γδ-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancerJeremy S Frieling, Leticia Tordesillas, Xiomar E Bustos, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cancer Immunology, Immunotherapy : CII|March 2, 2020
Neutrophils are mediators of metastatic prostate cancer progression in boneDiane L Costanzo-Garvey, Tyler Keeley, Adam J Case, et al.
Molecular Cancer Research : MCR|April 29, 2025
Targeted Deletion of Cxcl1 in MSCs Promotes Osteogenesis and Suppresses Bone Metastatic Prostate CancerCatherine S Johnson, Diane Costanzo-Garvey, Julio C Valencia, et al.
Nature Communications|March 20, 2024
The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant diseaseRyan T Bishop, Anna K Miller, Matthew Froid, et al.
Science Advances|May 3, 2023
γδ-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancerJeremy S Frieling, Leticia Tordesillas, Xiomar E Bustos, et al.
Pageof 2